MS
ELDN icon

Maven Securities’s Eledon Pharmaceuticals ELDN Stock Holding History

Maven Securities’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Buy
+100,000
New +$364K 0.01% 313
2021
Q1 		– Sell
-111,555
Closed -$1.72M – 1201
2020
Q4 		$1.72M Buy
+111,555
New +$2.13M 0.17% 160

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Maven Securities's ELDN Position: Q2 2026 in Review

Maven Securities opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 100,000 shares worth $394K. The stake represents 0.01% of the portfolio and ranks #313 among its holdings. This is a return to the name: Maven Securities previously reported a position in ELDN as recently as Q4 2020.

Maven Securities first reported a position in ELDN in Q4 2020 and has held it in 2 quarters since. The position peaked at $1.72M in Q4 2020. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Maven Securities held 100,000 shares of Eledon Pharmaceuticals worth $394K as of Q2 2026.
  • Eledon Pharmaceuticals was a new Maven Securities position in Q2 2026.
  • Eledon Pharmaceuticals made up 0.01% of Maven Securities's portfolio in Q2 2026, its #313 holding.
  • Maven Securities first reported a position in Eledon Pharmaceuticals in Q4 2020 and has held it in 2 quarters since.
  • Maven Securities's Eledon Pharmaceuticals position peaked at $1.72M in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.